Characteristic | n = 36 |
---|---|
Median age, years (range) | 71 (52–92) |
Gender | Â |
 Male | 29% (11) |
 Female | 69% (25) |
Myeloma type | n = 33 |
 IgG | 51% (17) |
 IgA | 3% (1) |
 Light chain only |  |
  Kappa | 36% (12) |
  Lambda | 9% (3) |
%MM cells in BM, range | 40% (5–95%) |
Bone lesions | 22 (61%) |
Number of previous therapies (range) | 2.5 (1–3) |